Male Factor Infertility - Urology Rounds · SEMEN CRYOPRESERVATION Oxidative Stress. 6 Associations...
Transcript of Male Factor Infertility - Urology Rounds · SEMEN CRYOPRESERVATION Oxidative Stress. 6 Associations...
1
Male Factor InfertilityMale Factor Infertility
Jeff McCrackenJeff McCracken
March 2007March 2007
Physeter macrocephalus
OutlineOutline
Oxidative Stress and InfertilityOxidative Stress and Infertility
Infertility GeneticsInfertility Genetics
Workup OverviewWorkup Overview
Assisted Reproductive TechnologiesAssisted Reproductive Technologies
2
DefinitionDefinition
1 year unprotected sex without 1 year unprotected sex without
pregnancypregnancy
15% of couples15% of couples
50% male factor50% male factor
50%
20%
30%
Female
Male
Combined
3
ImpactImpact
8 million couples in the United States8 million couples in the United States
1% to 10% of male factor infertility 1% to 10% of male factor infertility
–– ? Underlying disease? Underlying disease
AUA and American Society for AUA and American Society for
Reproductive Medicine (ASRM) Reproductive Medicine (ASRM)
–– Evaluation of male and female partners Evaluation of male and female partners
occurs in paralleloccurs in parallel
Surgery
History
Physical
Semen Analysis
Other Tests
Hormones
Medical
Therapy
ART
Basic Male Evaluation
4
Surgery
History
Physical
Ovulatory Fn
Anatomy
Ovarian Reserve
Medical
Therapy
ART
Basic Female Evaluation
Etiology of Male InfertilityEtiology of Male Infertility
VaricoceleVaricocele (35(35--40%)40%)
Idiopathic (25%)Idiopathic (25%)
Infection (~10%)Infection (~10%)
Genetic (15%)Genetic (15%)
Endocrine (<5%)Endocrine (<5%)
Immunologic (<5%)Immunologic (<5%)
Obstruction (<5%)Obstruction (<5%)
CryptorchidismCryptorchidism (<5%)(<5%) Greenberg et al, J UrGreenberg et al, J Urology 1978 ology 1978
5
Topics in Male InfertilityTopics in Male Infertility
PRIMARY SPERMATOGENIC FAILURE
TESTICULAR BIOPSY TECHNIQUES
TESE TECHNIQUES
TESE AND ICSI IN KLINEFELTER’S SYNDROME
COMBINATIONS WITH ICSI
INTRATESTICULAR OBSTRUCTION
VARICOCELE
HYPOGONADISM
CRYPTORCHIDISM
IDIOPATHIC MALE INFERTILITY
MALE CONTRACEPTION
MALE ACCESSORY GLAND INFECTIONS
GERM CELL MALIGNANCIES AND TESTICULAR MICROCALCIFICATIONS
ENDOCRINE DISRUPTION
DISORDERS OF EJACULATION
SEMEN CRYOPRESERVATION
Oxidative StressOxidative Stress
6
AssociationsAssociations
Infection
Varicocele
Cryptorchidism
Behavioural
Environmental
Reactive Oxygen SpeciesReactive Oxygen Species
Altered Altered acrosomeacrosome reactionreaction
Poor motilityPoor motility
DNA damageDNA damage
ApoptosisApoptosis
7
ManagementManagement
Lifestyle modification
– Smoking
– Exposure
Antioxidants
– Diet
– Vitamin EImproved acrosome reaction (ZBT)
In VitroIn Vitro
FutureFuture
Sperm Chromatin Structure Assay Sperm Chromatin Structure Assay
(SCSA) (SCSA)
PCR for DNA fragmentation
– Miscarriage high if SCSA >30%
– 16X success w/ IUI SCSA <27%
?Potential to become a useful tool in
infertility evaluation
– Does not r/o normal pregnancy
8
GeneticsGenetics
Mandatory in certain cases of male infertility to:Mandatory in certain cases of male infertility to:
Risk of disease transmission to childRisk of disease transmission to child
Prognostic factors for treatment successPrognostic factors for treatment success
Risk to future healthRisk to future health
DiagnosisDiagnosis
OverviewOverview
ICSI has revolutionized Rx for severe male ICSI has revolutionized Rx for severe male
factor infertilityfactor infertility
? Consequences of transmission of ? Consequences of transmission of
abnormal genes to offspringabnormal genes to offspring
Loss of natural selectionLoss of natural selection
= Devolution= Devolution
9
Canada
50%
10
11
ConnConn SmytheSmythe WinnersWinners
GameshowsGameshows
12
MiscellaneousMiscellaneous
BossBoss--Employee RelationsEmployee Relations
13
No change hereNo change here
MacNeilysMacNeilys
14
Genetic ConsiderationsGenetic Considerations
ClassificationClassification
1.1. Abnormalities of number or structure Abnormalities of number or structure
((KlinefelterKlinefelter’’ss))
2.2. Partial Chromosome Defects (YPartial Chromosome Defects (Y--
microdeletionmicrodeletion))
3.3. Specific Gene Defects (CF Mutation)Specific Gene Defects (CF Mutation)
15
Genetic ConsiderationsGenetic Considerations
Chromosomal abnormalities Infertile 5.8% vs. 0.38%
Sex chromosome abnormalities Infertile 4.2% vs. 0.14%
Autosomal abnormalitiesInfertile 1.5% vs. 0.25%
Abnormalities of numberAbnormalities of number
Polyploidy Polyploidy –– 23n23n
AneuploidyAneuploidy –– gain/loss gain/loss chromsomechromsome
(XXY, (XXY, TrisomyTrisomy 21)21)
16
Human Sperm Chromosomal Human Sperm Chromosomal
AneuploidyAneuploidy
Detected by FISHDetected by FISH
DisomyDisomy rate = ~0.1 rate = ~0.1 -- 0.2%0.2%
DiploidyDiploidy = ~0.1%= ~0.1%
= risk of miscarriage, fetal = risk of miscarriage, fetal aneuploidyaneuploidy
23,X 23,Y 24, XY
17
KlinefelterKlinefelter’’ss [46,XY; 47,XXY;
47,XXY mosaicism]
Most frequent sex chromosome
abnormality
1/1000 phenotypic males
Small firm testicles devoid of germ cells
Spectrum of normally virilized to:
– female hair distribution
– scanty body hair
– long arms and legs
KlinefelterKlinefelter’’ss
Germ cell presence and sperm production
are variable
Pre-implant FISH
Mosaic
– 24,XY sperm 0.9% - 2.1%
47,XXY
– 25% achieve meiosis
– ?haploid sperm in clone of normal cell
18
KlinefelterKlinefelter’’ss
Abnormal sperm/ Abnormal sperm/
embryos should not embryos should not
be implantedbe implanted
Patients require Patients require
lifelong endocrine lifelong endocrine f/uf/u
–– Risk of androgen Risk of androgen
deficiencydeficiency
Genetic ConsiderationsGenetic Considerations
19
X-linked genetic disorders
KallmannKallmann’’ss syndromesyndrome
–– Most common Most common X-linked recessive
– KALIG-1 gene on Xp 22.3
– Autosomal dominant variants
– Wide spectrum
Some only hypo hypo
– Treated with gonadotropins
Other XOther X--linkedlinked
Androgen InsensitivityAndrogen Insensitivity
–– Rare without genital abnormalityRare without genital abnormality
XpXp deletions (rare)deletions (rare)
20
YqYq--microdeletionmicrodeletion
1976 1976 –– TiepoloTiepolo & & ZuffardiZuffardi –– Long arm of Y Long arm of Y
chromosome may contain area for chromosome may contain area for
spermatogenesisspermatogenesis
““AzoospermicAzoospermic FactorFactor”” –– AZF AZF
YqYq--microdeletionmicrodeletion
1995 1995 –– ReijoReijo et alet al
““Deleted in Deleted in AzoospermiaAzoospermia RegionRegion”” DAZDAZ
21
Testicular failure 1-37%
Severe Oligospermia
1-17.3%
Sertoli Cell only 55%
YqYq--microdeletionmicrodeletion
GenotypeGenotype--Phenotype Phenotype
CorrelationCorrelation
AZFa SCOS
AZFb Maturation arrest
AZFc hypospermatogenesis
AZFd Disordered
spermatogenesis
22
YY--microdeletionsmicrodeletions
Yq
Yp5A
5E
AZFb
DFFRY
DBY
UTY
TB4Y
5M
6B
AZFa
E1F 1 AY
RBM
PRY
TTY2
6F
6C
AZFc
DAZ
BPY2
PRY
CDY
AZFd
Clinical RelevanceClinical Relevance
1.1. DiagnosticDiagnostic
2.2. PrognosticPrognostic
3.3. Affected OffspringAffected Offspring
23
Cystic Fibrosis and Male InfertilityCystic Fibrosis and Male Infertility
1969 1969 –– CF men CF men azospermicazospermic, all CBAVD, all CBAVD
1988 1988 –– CBAVD CBAVD �� IVFIVF
Cystic Fibrosis and Male InfertilityCystic Fibrosis and Male Infertility
Cystic Fibrosis Cystic Fibrosis transmembranetransmembrane conductance conductance
regulator gene (CFTR) chromosome 7regulator gene (CFTR) chromosome 7
AutosomalAutosomal recessive disorderrecessive disorder
Carrier Status Carrier Status 1 in 25 1 in 25
Cystic fibrosisCystic fibrosis 1 in 25001 in 2500
24
Cystic Fibrosis and Male InfertilityCystic Fibrosis and Male Infertility
Over 550 mutations have been found for Over 550 mutations have been found for
the CFTR genethe CFTR gene
Mild Mild �� SevereSevere
Infertility may be only manifestationInfertility may be only manifestation
–– MildMild
–– CarrierCarrier
Cystic Fibrosis and Male InfertilityCystic Fibrosis and Male Infertility
Clinical CF = CBAVD (95%)Clinical CF = CBAVD (95%)
Overall CBAVD = 1Overall CBAVD = 1--2% infertile men2% infertile men
1 mutation ~501 mutation ~50--82%82%
2 mutations ~10%2 mutations ~10%
Unilateral AVD = 43% CFTR mutationUnilateral AVD = 43% CFTR mutation
EpididymalEpididymal Obstruction = 47% CFTR Obstruction = 47% CFTR
mutationmutation
25
Congenital Bilateral Absence of Congenital Bilateral Absence of
Vas DeferensVas Deferens
Clinical diagnosisClinical diagnosis
Can be isolated Can be isolated
absence of vas absence of vas
deferens or deferens or
Absence of entire Absence of entire
Wolffian structures Wolffian structures
(distal (distal epiepi, seminal , seminal
vesicles, ejaculatory vesicles, ejaculatory
ducts)ducts)
Estimation of risk of having CF in Estimation of risk of having CF in
children of men with infertilitychildren of men with infertility
????1/12501/1250--15001500
Likely not severeLikely not severe
Sperm Sperm
AbnormalitiesAbnormalities
????1/1000 1/1000 -- 1500 1500
Likely not severeLikely not severe
EpididymalEpididymal obstobst
1/51/51/1501/150CBAVDCBAVD
Atypical CFAtypical CFCFCF
26
Renal Anomalies in CBAVDRenal Anomalies in CBAVD
Common derivation from Common derivation from mesonephmesoneph. duct. duct
–– vas deferens and vas deferens and uretericureteric budbud
Unilateral absence of VD Unilateral absence of VD
–– More commonMore common
Frequency of CF mutations in men Frequency of CF mutations in men
with infertilitywith infertility
Should all men with infertility be tested for Should all men with infertility be tested for
CF?CF?
–– Risk of clinically significant CF in the manRisk of clinically significant CF in the man
–– Risk of clinically significant CF in the childRisk of clinically significant CF in the child
Partner is main concern for Partner is main concern for testingtesting
27
WorkupWorkup
What?What?
Standard Standard
–– History History
(Questionnaire)(Questionnaire)
–– Physical Physical
examinationexamination
–– Standard semen Standard semen
analysisanalysis
Optional Additional Optional Additional
Evaluation:Evaluation:
–– Hormonal evaluationHormonal evaluation
–– Genetic evaluationGenetic evaluation
–– Specialized semen Specialized semen
and sperm function and sperm function
teststests
–– Imaging studiesImaging studies
–– Testis biopsyTestis biopsy
28
When?When?
1 year infertile1 year infertile
OROR
Male risk factorsMale risk factorsEgEg. bilateral . bilateral cryptorchidismcryptorchidism
Female risk factorsFemale risk factorsAge >35 yearsAge >35 years
Anxiety or questioning fertility potentialAnxiety or questioning fertility potential
HistoryHistory
GonadotoxinGonadotoxin exposureexposure
–– PesticidesPesticides
–– MedicationMedication
–– Recreational drugsRecreational drugs
–– Anabolic steroidsAnabolic steroids
–– SmokingSmoking
29
History: SmokingHistory: Smoking
Reduced sperm densityReduced sperm density
Decreased sperm functionDecreased sperm function
Increased sperm DNA fragmentation Increased sperm DNA fragmentation
Vine et al, Vine et al, FertilFertil SterilSteril 19941994
Vine et al, Vine et al, FertilFertil SterilSteril 19961996
Sun et al, Sun et al, BiolBiol ReprodReprod 19971997
Lab TestsLab Tests
Semen analysisSemen analysis
–– More than one sampleMore than one sample
–– Different spermatogenic cyclesDifferent spermatogenic cycles
–– Abstinence 2 to 3 daysAbstinence 2 to 3 days
–– Proper collection/ prompt analysisProper collection/ prompt analysis
30
SemenalysisSemenalysis
““Minimal Standards of AdequacyMinimal Standards of Adequacy””
–– Ejaculate volumeEjaculate volume 1.5 to 5 ml1.5 to 5 ml
–– Sperm densitySperm density >20 million/ml>20 million/ml
–– Total spermTotal sperm >40 million/ejaculate>40 million/ejaculate
–– MotilityMotility >50%>50%
–– Forward progressionForward progression >2 (0 to 4)>2 (0 to 4)
–– MorphologyMorphology >50% (>14% KSC) normal>50% (>14% KSC) normal
–– No significant agglutinationNo significant agglutination
–– No significant No significant pyospermiapyospermia
–– No No hyperviscosityhyperviscosity
Overview of TestsOverview of Tests
EndocrineEndocrine
Post Ejaculate UrinalysisPost Ejaculate Urinalysis
TRUSTRUS
Semen/sperm testsSemen/sperm tests
–– Leukocyte Leukocyte QuantitationQuantitation
–– AntispermAntisperm antibodiesantibodies
–– Sperm viability testsSperm viability tests
–– SpermSperm--cervical mucus interactioncervical mucus interaction
– Zona free hamster oocyte test
– Computer-aided sperm analysis
31
Workup of Low VolumeWorkup of Low Volume
Retrieve sperm
from bladder
Negative
no antegrade ejaculation
Use Sym agent
prior to sex
Positive
antegrade ejaculation
Sympathomimetic
Retrograde ejaculation
Resection of EDO
Ejaculatory duct
obstruction (EDO)
Low semen volume
Normal Volume Normal Volume AzoospermiaAzoospermia
Hypothalamic or
Pituitary deficiency
Low FSH
Obstructive
Azoospermia (OA)
Activespermatogenesis
Testis failure
Non-obstructive
azoospermia (NOA)
Reduced or nospermatogenesis
Testis Biopsy
Normal FSH
Testis failure
Non-obstructive
azoospermia (NOA)
High FSH
Azoospermia
32
Hormonal EvaluationHormonal Evaluation
normalnormal/highlowLH
ObstructionTestisHypothal-pit
normallowlowTest
normalhighlowFSH
NonNon--Obstructive Obstructive AzoospermiaAzoospermia
(NOA) (NOA)
HypospermatogenesisHypospermatogenesis (0(0--6 mature 6 mature spermatidsspermatids/tubule)/tubule)
Maturation arrestMaturation arrest(absence of mature (absence of mature spermatidsspermatids))
SertoliSertoli--cell onlycell only
33
Genetic screening
Karyotypic chromosomal abnormalities
Y-chromosome microdeletions
Cystic fibrosis gene mutations
Recommended Genetic TestingRecommended Genetic Testing
OligospermiaOligospermia
–– KaryotypeKaryotype
–– YY--MicrodeletionMicrodeletion
–– (CF Screen)(CF Screen)
Non Obstructive Non Obstructive AzospermiaAzospermia
–– KaryotypeKaryotype
–– YY--MicrodeletionMicrodeletion
Obstructive Obstructive AzospermiaAzospermia
–– CF ScreenCF Screen
34
Genetic DiagnosesGenetic Diagnoses
Patient educationPatient education
May uncover underlying pathologyMay uncover underlying pathology
Genetic CounselingGenetic Counseling
KaryotypeKaryotype
Peripheral leukocytes
Abnormality in 7% of infertile men
– Inversely Related to Sperm Count
10-15 % in azoospermic
5% in oligospermic
<1% in normospermic
35
Sex Chromosomal Aneuploidy
KlinefelterKlinefelter’’ss = 66% of abnormal= 66% of abnormal
Gross Gross karyotypickaryotypic abnormality = higher risk abnormality = higher risk
of congenital and chromosomal defects in of congenital and chromosomal defects in
offspringoffspring
Y-chromosome microdeletions
1010--15% 15% azoospermiaazoospermia/severe /severe oligooligo
PCR w/ tagged sequencesPCR w/ tagged sequences
Most deletions non-overlapping region
– long arm of the Y chromosome (Yq11)
36
CF gene mutationsCF gene mutations
CFTR on Chromosome 7CFTR on Chromosome 7
CBAVD in near all clinical CFCBAVD in near all clinical CF
66% of CBAVD has CF gene66% of CBAVD has CF gene
Partner becomes focusPartner becomes focus
37
Cystic Fibrosis and Male InfertilityCystic Fibrosis and Male Infertility
Workup SummaryWorkup Summary
Low vs. normal volume Low vs. normal volume azoospermiaazoospermia
CFTR and CFTR and KaryotypicKaryotypic abnormalities can abnormalities can
have impact on healthhave impact on health
All genetic diagnosis require counseling All genetic diagnosis require counseling
regarding risk to offspringregarding risk to offspring
Partners must be screened if CBAVDPartners must be screened if CBAVD
38
Assisted Reproductive Assisted Reproductive
Technologies (ART)Technologies (ART)
DefinitionDefinition
“Any procedure that requires
manipulation of gametes or embryos in
vitro”
39
IncludesIncludes
Intra uterine insemination (IUI)Intra uterine insemination (IUI)
IVFIVF
MicromanipulationsMicromanipulations
--Partial Partial ZonaZona Dissection (PZD)Dissection (PZD)
--Sub Sub zonalzonal injection of sperm (SUZI)injection of sperm (SUZI)
--Intra Intra cytoplasmiccytoplasmic sperm injection sperm injection
(ICSI)(ICSI)
OutcomesOutcomes
Pregnancy per cycle
Live birth per cycle
Live birth per egg retrieval
Live birth per transfer rate (highest)
Singleton live birth per cycle – Important ART outcome
– Singleton births = lower risk adverse outcomeslow birth weight
Disability
Death
Singleton live birth per transfer
40
DecisionsDecisions
IUI IndicationsIUI Indications
Cervical Factor – Anatomic or Physiologic
Low sperm quality
Antisperm antibodies
Men w/ problems of sperm delivery
– Hypospadias
– Impotence
41
IUIIUI
5 to 40 million motile
sperm
> 5 million motile
sperm inseminated
Success = 1% to 12%
–– Lower if MFILower if MFI
–– Higher than baselineHigher than baseline
IUIIUI
42
In vitro fertilization (IVF)
1) Controlled ovarian
stimulation
2) Egg retrieval
3) In vitro fertilization
4) Embryo transfer to the
uterus
IVFIVF
43
IVFIVF
OocytesOocytes incubated with washed sperm x incubated with washed sperm x
24 hours24 hours
Incubated 1Incubated 1--5 days5 days
Day 3 = 6 to 8-cell stage
Transferred to uterine fundus
Younger = fewer embryos
>40 years = 4-5 embryos
MorphologyMorphology
44
Intracytoplasmic sperm injection
(ICSI)
Sperm tail crushed = immotile
Injected through the ZP
– Through perivitelline space
– Into egg cytoplasm
Only need one sperm/egg
– ‘‘Immature’’ sperm
PR 30-40%
56% of IVF include ICSI
ICSIICSI
May use sperm from May use sperm from
Vas, Vas, EpididymisEpididymis, ,
TestisTestis
No evidence to No evidence to
demonstrate one area demonstrate one area
better (metabetter (meta--analysis)analysis)
45
Sperm selection, stabilization and Sperm selection, stabilization and
pick uppick up
Egg membrane penetration & Egg membrane penetration &
sperm injectionsperm injection
46
SUZI and ICSISUZI and ICSI
Past and Future ARTPast and Future ART
Gamete intra-fallopian transfer
Embryo culture manipulation
Pre-implantation genetic diagnosis
Gamete and embryo cryopreservation
Ovarian tissue freezing
47
Embry transferEmbry transfer
Indications for IVFIndications for IVF--ICSIICSI
AbsoluteAbsolute– Use of surgically retrieved sperm
Rare pregnancies from VD sperm w/ IUI
Relative indications– Immunological infertility
– Failure to conceive w/ IUI
– <5 million/ejaculate
– Poor sperm morphology
– Male genetic infertilityY chromosome microdeletions
Karyotype abnormalities
– Low motile sperm count
48
Advanced Maternal AgeAdvanced Maternal Age
ComplicationsComplications--FemaleFemale
Ovarian torsion
Ovarian hyperstimulation syndrome (OHSS)
– Excessive gonadotropin stimulation
– Severe = <1% of IVF cycles
– Can be life threatening
– Dramatic increase in estrogen
Electrolyte imbalances
Hypovolemia
Thrombotic events/DVT/PE
49
ComplicationsComplications--FemaleFemale
Procedure related
– <1%
Procedure associated
–Multiple births (35% vs 1%)
lower birth weights
higher complication rates
Increased learning disabilities
– Birth defect
– Imprinting disorders
OffspringOffspring
Major birth defects (3.3%)
– Equivalent with intercourse
Risks of sex chromosome anomalies
– 0.8% vs. 0.2%
– Infertility
Hypospadias (1.6% vs. 0.3%)
Imprinting disorders
– Beckwith-Weideman syndrome
– Anglemann syndrome
50
Cost EffectivenessCost Effectiveness
VaricocelectomyVaricocelectomy vs. IVF/ICSIvs. IVF/ICSI
–– ??VaricocelectomyVaricocelectomy effectiveeffective
3030--50% Severe MFI 50% Severe MFI ““rescuedrescued””
–– Not effective Not effective
Y Y microdeletionmicrodeletion
KaryotypeKaryotype abnormalityabnormality
Cost EffectivenessCost Effectiveness
VV/VE vs. ARTVV/VE vs. ART
– Vasectomy reversal likely cheaper
– >10 year vasectomies still cheaper
– Advanced maternal age cheaper
VV/VE requires patency rate of >79%
– Quality standards imperative
51
Sperm Retrieval OptionsSperm Retrieval Options
EpididymalEpididymal or or testicular sperm for testicular sperm for OAOA
Testicular sperm Testicular sperm (micro(micro--TESE) for TESE) for NOANOA
ElectroElectro--ejaculation ejaculation or or vibrovibro--stimulation stimulation for for anejaculationanejaculation..
MicroMicro--TeseTese
Larger tubules =SpermLarger tubules =Sperm
Thinner tubules =SCO Thinner tubules =SCO
Operating microscope view
SCO
Sperm
52
MicroMicro--TeseTese Success RatesSuccess Rates
Retrieval Attempts N=81Retrieval Attempts N=81
Sperm Retrieval 58% (47/81)Sperm Retrieval 58% (47/81)
Fertilization Rate 61% (268/439)Fertilization Rate 61% (268/439)
Clinical Pregnancy 55% (26/47)Clinical Pregnancy 55% (26/47)
Ongoing/Delivery 40% (19/47)Ongoing/Delivery 40% (19/47)
Overall Pregnancy 32% (26/81)Overall Pregnancy 32% (26/81)
Cornell University Web site
53
ART SummaryART Summary
IUI if >5 million spermIUI if >5 million sperm
IVF more successful with ICSIIVF more successful with ICSI
VaricocelectomyVaricocelectomy and VV/VE still more cost and VV/VE still more cost
effective for patienteffective for patient
MicroMicro--TeseTese good success with minimal good success with minimal
damage to testicledamage to testicle